|
Post by respect on Apr 23, 2014 18:50:44 GMT -5
Yeah. I heard parexel is known for poop party studies. Chocolate ice cream factory
|
|
|
Post by respect on Apr 23, 2014 13:28:11 GMT -5
Heard dr Parsad was very adamant in using the finger probe. If u insisted on pooping you got a urine cup and probably given the difficulty of not pooping on your hand u would just let her probe you.
|
|
|
Post by respect on Apr 21, 2014 12:51:39 GMT -5
Bloody stool! I hope it was not the prostate because I dont know any females who would pass the exam!
|
|
|
Post by respect on Apr 19, 2014 19:20:47 GMT -5
For some having higher bilirubin level is a norm. If you have alot of blood loss which is common with doing too many studies the body may produce alot of immature red blood cells (rbc)to compensate. These smaller immature blood cells don't last as long and the body destroys them with the by product being bilirubin. As you ue to donate blood the cycle ues. Condition such gall bladder stones can also interfere with liver ability to clear bilirubin as it interfers with bile flow into the intestines. A fatty high processed food diet promotes gall stones.
|
|
|
Post by respect on Apr 19, 2014 16:03:58 GMT -5
Sorry to all you guys who got finger popped and no call back. Next time bring your own $hi+ sample so they don't have to stick you were the sun don't rise.
Clinilabs does not mean any harm by it. They are just in a city where one nite stands are all too common. And to all those of you who made it .You assumed the position like pros. You are to be commended. You now have a new skill set that will make you some extra cash or at least a new hobby!
|
|
|
Post by respect on Mar 28, 2014 12:22:07 GMT -5
If you are taking thyroid hormone and doing studies, it sounds like you are trying to speed up your appointment with a coroner. If you have life insurance you should make Jones the beneficiary.
|
|
|
Post by respect on Feb 22, 2014 16:41:52 GMT -5
Interpreting your blood test results
Doctors generally look first at the level of the liver enzyme GGT. Generally speaking in “normal liver function tests” the level of GGT is not greater than 45.
If your GGT is greater than 100, the doctor will look at the levels of the other liver enzymes to try and work out possible causes of liver damage. Let’s take a look at some possible combinations of abnormally high liver enzymes and what that could mean.
For example:
If your GGT is above 100, and your ALT is less than 80 and your ALP is less than 200 This could mean that:
You are drinking too much alcohol You are taking recreational drugs such as ice or heroin You have diabetes You have a fatty liver You have very high levels of the blood fat called triglycerides You are taking certain prescribed drugs that have stimulated your liver to make more enzymes for example – barbiturates, benzodiazepines, anticonvulsants, warfarin, tricyclic antidepressants, paracetamol, pain or immunosuppressants. Note: in some people it is normal for GGT levels to be as high as 120, with no liver problems being found.
If your GGT is above 100, and your ALT is less than 80 and your ALP is above 200 This could mean that:
The flow of bile is being slowed down or obstructed and this could be from a gall stone in the bile ducts, very inflamed bile ducts or a tumour inside the liver or a tumour outside the liver which is pressing on the bile ducts. Excess drugs or alcohol can slow the flow of bile Scarring of the liver (known as cirrhosis) can distort the bile ducts and cause slowing/obstruction to the flow of bile. You have liver disease plus bone disease, as the enzyme ALP can also be elevated by some bone diseases Note: when the flow of bile is obstructed or slowed, the level of bile (bilirubin) becomes elevated in the blood to above 20 and the patient may turn yellow (jaundiced).
If your GGT is above 100, and your ALT is above 80 and your ALP is less than 200 This could mean that:
The liver cells are inflamed by certain viruses such as the Hepatitis A, B or C viruses or the glandular fever virus (Epstein Barr Virus). You are taking liver toxic drugs or drinking excess alcohol You have a fatty liver If your GGT is above 100, and your ALT is above 80 and your ALP is above 200 This could mean that the liver cells are damaged plus there is slowing or obstruction to the flow of bile and this can occur in the following liver diseases:
Acute hepatitis from viral infections or drug or alcohol toxicity Chronic (long term) hepatitis from viral infections, alcohol excess or autoimmune diseases Tumours inside or near the liver which obstruct the flow of bile Scarring of the liver (cirrhosis) Note: in alcoholic liver disease the level of the other liver enzyme AST is often elevated to high levels as well, and is usually higher than the level of ALT.
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) represents the most common form of liver disease and is considered to be the liver manifestation of Syndrome X (the metabolic syndrome).
Within the degrees and types of NAFLD, simple fatty accumulation (hepatic steatosis) is not considered to be highly dangerous in itself although it can lead to weight excess and diabetes. However the more severe form of fatty liver known as non-alcoholic steato-hepatitis (NASH) may progress to cirrhosis and liver failure. The distinction can be made by liver biopsy.
There is not complete agreement on the criteria for diagnosis or the features used for grading and staging lesions. Both types of fatty liver disease are reversible and the key is earlier diagnosis and the use of nutritional medicine.
|
|
|
Post by respect on Feb 21, 2014 3:27:26 GMT -5
May be the staff they layed off in the teens are being malicious but all signs point to that end. Very active study schedules at other sites and retirement of probably the best and most professional PI I have met in the industry are all indicators. Dr Connelly is more than a person with a doctorate to her name. She is first and foremost a physician. The difference is a doctor has a degree. A physician possesses a gift and are fewer in numbers. May be we will see her in CT, MD, NY,MA or where everything is bigger-The Lone Star State.
|
|
|
Post by respect on Feb 20, 2014 17:49:03 GMT -5
Snbl has no studies. Celerion is closing. It would appear to me that vct would be mostly useless for them to put in place now. It woukd be a profit drainer too.
|
|
|
Post by respect on Aug 22, 2013 15:12:18 GMT -5
|
|
|
Post by respect on Aug 22, 2013 15:06:58 GMT -5
If anyone can shed any light on this, I would greatly appreciate it. I am sure to get many "it varies from study to study" and "it depends on the sponsor" and so forth. But what I am really looking for is some insight on the relative weight given to BP and, more importantly, the manner in which is considered. Let me explain... Recall in high school or college, every once in a while you would have a course that was simply graded on a PASS/FAIL basis. That is, there was no uum of grading in the course (A, B, C, D, etc...). You either passed the course, or you failed it. Everyone who passed was considered equal no matter whether they passed with a 97% or a 71%. There were no degrees of success. Only a yes/no. So my question is whether or not this is the way that the Blood Pressure check (in Vitals) works in most screenings. Suppose a study has a target blood pressure range of, say, 118/70 to 139/89. So they are only admitting subjects whose BP falls in between those two figures. Now, does that mean that everyone who's BP is in that range will be subsequently considered equal IN TERMS OF BP? Or, rather, is preference or weight given to the bottom end of the range? I would initially think that preference is given to the lower end of the range. However, I then thought that maybe I was -- in my medical ignorance -- overvaluing the importance of blood pressure and not realizing that what they are most concerned with is blood work/labs, and that things like vitals are only very preliminary checks, such that if you pass you pass (and they go on to consider your blood work/labs) and if you fail, you fail (and you are cut from consideration all together). If anyone can shed some light on this question I would REALLY appreciate it. I recently screened for a big study, got in, but was then eliminated by the randomization process on the first day (they had to cut a few of us). So then I screened for the next group/cohort... but I was so nervous about getting in again that my BP was way toward the top end of the range. So naturally I'm suddenly very curious about the type of consideration that BP is. Hence my question above. Thanks in advance to anyone who can shed some light!
|
|
|
Post by respect on May 30, 2013 15:24:15 GMT -5
The same thing may happen to you again if the specific study requires the same test. You may need to see an endocrinologist to see what the problem is. Thyroid disease is very serious. I can imagine you are very lean in appearance. It possible if you are exposed to a medication that is pro drug that you may metabolize it to quickly and it could quickly become very toxic. You could move from becoming a subject to patient or being placed under the administration of a medical examiner
|
|
|
Post by respect on May 9, 2013 17:49:51 GMT -5
I have hypothetical questions. If Dr.Efros' patient under his supervision enrolls in clinical trial how does the verification system handles this scenario. Would he then propose that his patient be registered in a database to eliminate this possibility.
Such a scenario is in the realm of possibilities. Would a concurrence of his patient in trial while under his supervision justify a broader infringement of patients HIPAA rights? Can a Clinical Research Unit now insist on contacting one's doctor to allow participating in a study? Its in the realm imagination that anyone's doctor has critical health risk information about an individual. Why don't we just create a mass database with some minimal identifying code that allow pathway to a clinician to quickly assess those risk and also include Mitchell EFROS M.D. patients? OOPs we have soing called HIPAA.
When any doctor indulges in chipping away at HIPAA rights society should be wary of that doctor and a patient should do his or her due diligence and commit only to a doctor that share his or her privacy values.
|
|
|
Post by respect on May 1, 2013 16:28:07 GMT -5
|
|
|
Post by respect on Apr 26, 2013 7:12:27 GMT -5
The profiteers who own these database dont care whether we debate who own their companies or if their ads are poorly made. They have nothing to lose unless we legally challenge their infringements under HIPAA. They have proceeded with little regard because of their eption of lab rats as class B citizens not worthy of the protection of HIPAA. This class B citizenship conferred on subjects by clinical research units eminates from society at large.
We are well aware that many research subjects are minorities. This further impacts how you are treated in these units and yes the liberty they take with your privacy under HIPAA simple because you are eived of not worthy of those privileges or not intelligent enough to challenge your assigned class B status. What you are encouraged to do is discuss the issues with members of your community. A family, a friend, a teacher, a pastor, your account, your lawyer and see if they would be comfortable being herded into a database. We need investigate the application of these database where research unit participants over all are mostly white. The results may surprise you.
|
|